[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.241.199. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Clinical Challenges in Otolaryngology
February 1999

Is There Still a Role for Auditory Brainstem Response Audiometry in the Diagnosis of Acoustic Neuroma?

Author Affiliations

From the Department of Otolaryngology–Head and Neck Surgery, University of California Davis Medical Center, Sacramento.

 

KAREN H.CALHOUNMDRONALD B.KUPPERSMITHMD

Arch Otolaryngol Head Neck Surg. 1999;125(2):232-234. doi:10.1001/archotol.125.2.232

All patients with newly documented asymmetrical sensorineural hearing loss should undergo auditory brainstem response (ABR) audiometry. If the results are normal, magnetic resonance imaging (MRI) is not required to rule out acoustic neuroma.

Acoustic neuroma, which is more commonly but less accurately called acoustic neuroma, is the most frequently occurring neoplasm of the cerebellopontine angle. Each year in the United States, 2000 to 3000 new cases are diagnosed.1 The most common symptom of acoustic neuroma, progressive asymmetrical sensorineural hearing loss, is found in 80% to 95% of patients, depending on the size of the tumor.2 Definitive diagnosis of acoustic neuroma is possible with nearly perfect sensitivity and specificity using gadolinium-enhanced MRI of the internal auditory canals. However, even in a neurotology referral center, only 5% of patients with asymmetrical sensorineural hearing loss or unilateral tinnitus actually have a finding on MRI that could account for their hearing loss and only 1% are diagnosed as having acoustic neuroma.3 Thus, 99% of patients with the typical presenting symptoms of acoustic neuroma will not have a tumor on their scan. Therefore, the cost-effectiveness of routinely performing MRI has been called into question.

First Page Preview View Large
First page PDF preview
First page PDF preview
×